Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-05-002174
Filing Date
2005-12-06
Accepted
2005-12-06 17:55:20
Documents
1
Period of Report
2005-12-02

Document Format Files

Seq Description Document Type Size
1 form4_120605-biocrystex.html 4  
1 form4_120605-biocrystex.xml 4 4060
  Complete submission text file 0000947871-05-002174.txt   5842
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 787 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017 2127396400
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 051247981